High-throughput metabolomics identifies new biomarkers for cervical cancer

被引:0
作者
Xue Li
Liyi Zhang
Xuan Huang
Qi Peng
Shoutao Zhang
Jiangming Tang
Jing Wang
Dingqing Gui
Fanxin Zeng
机构
[1] Dazhou Central Hospital,Department of Clinical Research Center
[2] Dazhou Central Hospital,Department of Gynaecology and Obstetrics
[3] Beijing Chaoyang Hospital,Department of Medical Research Center
[4] Capital Medical University,Department of Clinical Laboratory
[5] Beijing Anding Hospital,undefined
[6] Capital Medical University,undefined
来源
Discover Oncology | / 15卷
关键词
Cervical cancer; Metabolites; Trimethylamine ; -oxide; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 286 条
[1]  
Arbyn M(2020)Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Lancet Glob Health 8 e191-e203
[2]  
Weiderpass E(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA A Cancer J Clin 68 394-424
[3]  
Bruni L(2020)Cervical cancer screening for individuals at average risk: 2020 guideline update from the American cancer society CA A Cancer J Clin 145 129-135
[4]  
de Sanjosé S(2019)Revised FIGO staging for carcinoma of the cervix uteri Int J Gynaecol Obstet 393 169-182
[5]  
Saraiya M(2019)Cervical cancer Lancet 48 155-171
[6]  
Ferlay J(2002)Metabolomics–the link between genotypes and phenotypes Plant Mol Biol 36 316-320
[7]  
Bray F(2018)Metabolomics activity screening for identifying metabolites that modulate phenotype Nat Biotechnol 16 565-577
[8]  
Bray F(2012)Global profiling strategies for mapping dysregulated metabolic pathways in cancer Cell Metab 16 339-362
[9]  
Ferlay J(2019)Cancer metabolomic markers in urine: evidence, techniques and recommendations Nat Rev Urol 40 5853-5859
[10]  
Soerjomataram I(2013)Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection Mol Biol Rep 6 3937-3942